Active ingredient
Ixekizumab
4 finished FDA listings contain Ixekizumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- IXEKIZUMAB
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 20 mg/.25ml · 40 mg/.5ml · 80 mg/ml
- Brand names in FDA listings
- Taltz
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1745099
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 125521 | ELI LILLY AND CO | 2016-03-22 | 4 |
Official labeling on DailyMed
- TALTZ (IXEKIZUMAB) INJECTION, SOLUTION [ELI LILLY AND COMPANY] · version 40 · 2026-06-23
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.